Background and rationale for use of anticonvulsants in psychiatry.
Sussman
N
N
New York University School of Medicine, NY 10021-5835, USA.
D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D000927:Anticonvulsants / Q000266:history / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy; D000077206:Gabapentin; D049673:History, 20th Century; D006801:Humans; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D010146:Pain / Q000150:complications / Q000188:drug therapy; D011570:Psychiatry / Q000266:history; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin